Market revenue in 2022 | USD 7.7 million |
Market revenue in 2030 | USD 14.5 million |
Growth rate | 8.2% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 38.96% in 2022. Horizon Databook has segmented the Saudi Arabia sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The sepsis diagnostics market in Saudi Arabia is driven by the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases. According to a study published by the National Library of Medicine in April 2024, brucellosis, tuberculosis, and salmonellosis are the most frequently reported bacterial infections in Saudi Arabia.
The study found that brucellosis and tuberculosis primarily impact males, while salmonellosis is more common among Saudi citizens. The government’s Vision 2030 initiative is significantly enhancing healthcare infrastructure, leading to improved diagnostic capabilities. In addition, pulmonary tuberculosis is notably more prevalent among non-Saudi residents.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account